Altimmune, Inc.
ALTNASDAQHealthcare● Active
$2.73
+$0.02(+0.74%)
Market Cap$240942429
P/E Ratio—
52W High$7.73
52W Low$2.56
Altimmune, Inc.（ALT）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ALT · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($88.09M) | ($95.06M) | ($88.45M) | ($84.71M) | ($97.09M) |
| Depreciation & Amort. | $0.11M | $0.24M | $0.48M | $0.49M | $0.55M |
| Stock-Based Comp. | $16.08M | $14.39M | $10.64M | $8.10M | $5.52M |
| Change in Working Capital | $6.75M | $4.48M | ($8.27M) | $14.11M | ($0.25M) |
| Net Cash from Operations | ($67.53M) | ($79.85M) | ($75.81M) | ($62.59M) | ($78.24M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.01M) | $0.00M | ($0.05M) | ($0.13M) | ($12.31M) |
| Purchases of Investments | ($285.45M) | ($115.73M) | ($88.63M) | ($73.27M) | ($7.59M) |
| Sales of Investments | $152.99M | $87.34M | $102.41M | $0.00M | $107.43M |
| Net Cash from Investing | ($132.47M) | ($28.39M) | $13.73M | ($73.40M) | $87.52M |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $33.92M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Financing | $206.84M | $10.04M | $86.11M | $56.78M | $65.10M |
| Free Cash Flow | |||||
| Free Cash Flow | ($67.55M) | ($79.85M) | ($75.86M) | ($62.71M) | ($90.55M) |
| FCF Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解Altimmune, Inc.
关于Altimmune, Inc.（ALT）现金流量表
Altimmune, Inc. 2025财年经营活动现金流($0.07B)，自由现金流($0.07B)（FCF利润率-164746.34%），资本支出($0.00B)。
常见问题
ALT · 4 问Altimmune, Inc. 2025财年自由现金流($0.07B)，同比up15.4%。
ALT free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10